Table 1 Characteristics of patients and their MGMT promoter methylation status determined by HRM, MSP, and PSQ in 83 malignant gliomas, including 18 IDH1-mutated cases
Characteristics | n | HRM me (%) | MSP me (%) | PSQ me (%) | IDH1 mut (%) |
|---|---|---|---|---|---|
All patients | 83 | 51.8 | 37.3 | 54.2 | 21.7 |
Woman | 28 | 50.0 | 39.3 | 53.6 | 21.4 |
Man | 55 | 52.7 | 36.4 | 54.5 | 21.8 |
Age ≥70 | 27 | 44.4 | 25.9 | 44.4 | 0.0 |
Age <70 | 56 | 55.4 | 42.9 | 58.9 | 32.1 |
Grade III | 23 | 73.9 | 56.5 | 69.6 | 69.6 |
Grade IV | 60 | 43.3 | 30.0 | 48.3 | 3.3 |